Join, share, learn and collaborate 48 leading life science organisations, and growing. Celebrating 12 Years Shaping the Future of Pharmacovigilance
Big changes, coming soon to a pharmaco near you! Nostrapharmus predicts big changes in the way R&D projects are selected, big changes in the role of the regulator. Very soon, a general adoption of risk management in regulation and in development investment will increase both flexibility and safety, and it will greatly enhance the industry's capacity to develop drugs for future need.
What's driving change?
The present, paper‑heavy system of regulation doesn't stop Serious Adverse Events (SAEs). And when things go wrong, tick the right boxes and your pharmaco's probably off the hook – legally, at least. But the public wants heads to roll. Who's next in line? No wonder the regulators are looking for a new approach!